|
Variable
|
Value
|
|---|
|
Patients, n
|
233
| |
|
Male sex, n (%)
|
182
|
(78.11)
|
|
Age, M (range)
|
54
|
(25–73)
|
|
CTP class A/B/C, n (%)
|
227/6/0
|
(97.42/2.58/0)
|
|
Tumor maximum size, cm, M (range)
|
4.1
|
(2.1–9.7)
|
|
HBV DNA, log copies/ml
|
3.9
|
(3.0–5.1)
|
|
HBeAg postive, n (%)
|
164
|
(70.39)
|
|
Cirrhosis, n (%)
|
96
|
(41.20)
|
|
AFP, ng/mL, M (range)
|
103.7
|
(7.8–1210)
|
|
TBIL, mmol/L, M (range)
|
5.87
|
(2.60–64.70)
|
|
ALT, IU/L, M (range)
|
26
|
(11–57)
|
|
AST, IU/L, M (range)
|
27
|
(19–78)
|
|
ALP, IU/L, M (range)
|
51
|
(45–187)
|
|
ALB, g/L, M (range)
|
3.9
|
(2.3–5.7)
|
|
PLT, 10^9/L, M (range)
|
163.5
|
(79–241)
|
|
PT, s, M (range)
|
12.1
|
(11.3–13.6)
|
|
INR, M (range)
|
0.99
|
(0.77–1.24)
|
- AFP = α-fetoprotein, ALB = albumin, ALP = alkaline phosphatase, ALT = alanine aminotransferase, AST = aspartate aminotransferase, CTP=Child–Trucott–Pugh score, HBV = hepatitis B virus, INR = international normalized ratio, PLT = platelet, PT = prothrombin time, TBIL = total bilirubin
